Personalizing
Cancer Treatment for Everyone

Drug used to treat lung tumours may also work on breast cancer patients

April 6, 2018

The drug, crizotinib, targets a genetic defect that is found in around 7,000 breast cancer patients in the UK each year.

It is already used to treat non-small cell lung cancer by shrinking tumours.

Medics hope it can now be “repurposed” for women with the gene-related form of the disease.

Baroness Delyth Morgan, of charity Breast Cancer Now, called the discovery “extremely exciting”.

The new approach targets cells with faulty versions of a protein called E-cadherin.

This protein helps to bind healthy cells together but when defective it causes cancer cells to grow and divide abnormally.

Read More

Stay in Touch with Us
To speak with a dedicated cancer care specialist, contact us:
PLEASE FILL OUT FORM BELOW

By clicking Submit, you agree to our Terms And Conditions and have read and acknowledge our Privacy Statement.

Top